Technical Analysis for COLL - Collegium Pharmaceutical, Inc.

Grade Last Price % Change Price Change
D 23.27 -0.81% -0.19
COLL closed down 0.81 percent on Friday, April 16, 2021, on 31 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical COLL trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish -0.81%
Fell Below 20 DMA Bearish -0.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.81%
50 DMA Resistance Bearish -3.12%
Crossed Above 20 DMA Bullish -3.12%
Narrow Range Bar Range Contraction 1.57%
NR7 Range Contraction 1.57%
Inside Day Range Contraction 1.57%
Pocket Pivot Bullish Swing Setup -0.26%
Spinning Top Other -0.26%
Older End-of-Day Signals for COLL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Collegium Pharmaceutical, Inc. Description

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Diseases Pain Chemical Compounds Organic Compounds Opioid Euphoriants Chronic Pain Ethers Platform Technology Morphinans Opioids Attention Deficit Attention Deficit Hyperactivity Disorder Hyperactivity Disorder Treatment Of Chronic Pain Hydrocodone Phenols Methylphenidate Treatment Of Attention Deficit Hyperactivity Disorder Oxycodone Morphine Oxymorphone

Is COLL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.91
52 Week Low 15.66
Average Volume 568,758
200-Day Moving Average 20.55
50-Day Moving Average 24.09
20-Day Moving Average 23.72
10-Day Moving Average 23.32
Average True Range 1.05
ADX 12.02
+DI 21.17
-DI 21.35
Chandelier Exit (Long, 3 ATRs ) 22.81
Chandelier Exit (Short, 3 ATRs ) 25.48
Upper Bollinger Band 25.23
Lower Bollinger Band 22.21
Percent B (%b) 0.35
BandWidth 12.73
MACD Line -0.21
MACD Signal Line -0.19
MACD Histogram -0.0216
Fundamentals Value
Market Cap 804.73 Million
Num Shares 34.6 Million
EPS 0.51
Price-to-Earnings (P/E) Ratio 45.90
Price-to-Sales 2.09
Price-to-Book 3.71
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.51
Resistance 3 (R3) 24.50 24.09 24.30
Resistance 2 (R2) 24.09 23.77 24.09 24.23
Resistance 1 (R1) 23.68 23.58 23.47 23.68 24.16
Pivot Point 23.26 23.26 23.16 23.26 23.26
Support 1 (S1) 22.85 22.95 22.65 22.86 22.38
Support 2 (S2) 22.44 22.75 22.44 22.31
Support 3 (S3) 22.03 22.44 22.24
Support 4 (S4) 22.03